A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds.

A screening method for trace analysis of potentially genotoxic alkylating compounds has been developed using butyl 1-(pyridin-4-yl) piperidine 4-carboxylate (BPPC) as a new, selective pre-column derivatization reagent for their subsequent analysis by hydrophilic interaction liquid chromatography (HILIC) hyphenated with tandem mass spectrometry (LC-MS/MS). The new derivatization reagent is a modification of 4-dimethylaminopyridine (4-DMAP) previously used for the determination of potentially genotoxic compounds. By using the new reagent the screening potential was enhanced without compromising reactivity. Derivatization at a high pH value was carried out and the reaction time at 60°C was 24h to anticipate for alkyl chlorides showing to be less reactive. The new reagent was designed to obtain reagent related fragmentation of the whole reagent as well as a side group of the reagent. Collision energies for detection of alkylating components derivatized using the new reagent are shown to be significantly more universal than with 4-DMAP. Neutral loss scanning on the fragmentation related to the build in side group remedies shortcomings in the screening for alkyl halides observed when using 4-DMAP. The new approach allows for screening of alkyl halides and alkyl sulfonates at trace levels down to 1 mg kg(-1) and target analysis at about a factor of 10 lower without a significant effect of the active pharmaceutical ingredient (API) matrix. The synthesis of the reagent, investigation of reactivity, the specificity of the fragmentation of derivatives and screening conditions in MS/MS analysis are described.

[1]  I. D. de Esch,et al.  Targeted LC–MS derivatization for aldehydes and carboxylic acids with a new derivatization agent 4-APEBA , 2010, Analytical and bioanalytical chemistry.

[2]  David Q. Liu,et al.  Recent advances in trace analysis of pharmaceutical genotoxic impurities. , 2010, Journal of pharmaceutical and biomedical analysis.

[3]  Derek Robinson,et al.  Control of Genotoxic Impurities in Active Pharmaceutical Ingredients: A Review and Perspective , 2010 .

[4]  P. Domingues,et al.  Constant neutral loss scanning for the characterization of glycerol phosphatidylcholine phospholipids , 1998 .

[5]  David Q. Liu,et al.  A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. , 2008, Journal of pharmaceutical and biomedical analysis.

[6]  T. Santa Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry. , 2011, Biomedical chromatography : BMC.

[7]  G. J. Jong,et al.  A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis , 2011, Analytical and bioanalytical chemistry.

[8]  G. Hopfgartner,et al.  Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer. , 2003, Journal of mass spectrometry : JMS.

[9]  G. V. Van Berkel,et al.  Chemical Derivatization for Electrospray Ionization Mass Spectrometry. 1. Alkyl Halides, Alcohols, Phenols, Thiols, and Amines , 1994 .

[10]  Sherry Wang,et al.  Trapping 4-fluorobenzyl chloride in human plasma with chemical derivatization followed by quantitative bioanalysis using high-performance liquid chromatography/tandem mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[11]  J. Trottier,et al.  Book Review: Mass Spectrometry: Principles and Applications. E. de Hoffman, J. Charette and W. Stroobant. Wiley, Chichester 1996. ISBN 0 471 96697 5 , 1997 .

[12]  D. Elder,et al.  Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[13]  D. Chace,et al.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. , 2003, Clinical chemistry.

[14]  Lutz Müller,et al.  A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[15]  J. Halket,et al.  Derivatization in Mass Spectrometry—8. Soft Ionization Mass Spectrometry of Small Molecules , 2006, European journal of mass spectrometry.

[16]  Nigel Greene,et al.  The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. , 2006, Regulatory toxicology and pharmacology : RTP.

[17]  D. Elder,et al.  Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[18]  H. Wortham,et al.  Carboxylic acid functional group analysis using constant neutral loss scanning-mass spectrometry. , 2007, Analytica chimica acta.